Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Gains from Investment Securities (2021 - 2026)

ADC Therapeutics has reported Gains from Investment Securities over the past 6 years, most recently at -$2.2 million for Q1 2026.

  • Quarterly results put Gains from Investment Securities at -$2.2 million for Q1 2026, down 460.96% from a year ago — trailing twelve months through Mar 2026 was -$2.2 million (down 262.52% YoY), and the annual figure for FY2025 was $46000.0, down 93.12%.
  • Gains from Investment Securities reached -$2.2 million in Q1 2026 per ADCT's latest filing, down from $472000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.2 million in Q2 2024 and bottomed at -$2.2 million in Q1 2026.
  • Median Gains from Investment Securities over the past 5 years was -$55500.0 (2022), compared with a mean of -$44166.7.
  • Peak annual rise in Gains from Investment Securities hit 11100.0% in 2024, while the deepest fall reached 707.14% in 2024.
  • Over 5 years, Gains from Investment Securities stood at -$91000.0 in 2022, then surged by 406.59% to $279000.0 in 2023, then surged by 139.78% to $669000.0 in 2024, then dropped by 29.45% to $472000.0 in 2025, then plummeted by 571.82% to -$2.2 million in 2026.
  • Business Quant data shows Gains from Investment Securities for ADCT at -$2.2 million in Q1 2026, $472000.0 in Q4 2025, and -$426000.0 in Q3 2025.